Item
8.01. Other Events.
Actions
in Connection with Extraordinary General Meeting
As
previously disclosed, Cactus Acquisition Corp. 1 Limited, a Cayman Islands exempted company (“Cactus” or the “Company”)
has called an extraordinary general meeting in lieu of 2023 annual general meeting of the Company to be held at 9:00 a.m. Eastern Time/4:00
p.m. local (Israel) time on April 20, 2023 (the “Meeting”) for the sole purposes of considering and voting on, among
other proposals:
| ● | A
proposal to approve, by way of special resolution, an amendment to Cactus’ Amended
and Restated Memorandum and Articles of Association (the “Articles”) to
extend the date (the “Termination Date”) by which Cactus has to consummate
a business combination (the “Extension”) from May 2, 2023 (the “Original
Termination Date”) to November 2, 2023 (the “Extension Date”)
or such earlier date as may be determined by Cactus’ board of directors (the “Board”)
in its sole discretion (the “Articles Extension Proposal”); |
| ● | A
proposal to amend the Company’s investment management trust agreement, dated as of
November 2, 2021 (the “Trust Agreement”), by and between the Company and
Continental Stock Transfer & Trust Company (“Continental,” or the
“Trustee”), to provide for the Extension to the Extension Date pursuant
to the Articles Extension Proposal (the “Trust Extension Proposal”); and |
| ● | A
proposal to approve, by way of special resolution, an amendment to Cactus’ Articles
to provide for the right of a holder of Class B ordinary shares, par value $0.0001 per share
(“Class B ordinary shares”) to convert such shares into Class A ordinary
shares, par value $0.0001 per share (“Class A ordinary shares”) on
a one-for-one basis prior to the closing of a business combination at the election
of the holder (the “Conversion Amendment”) (the “Conversion Amendment
Proposal”). |
On
April 11, 2023, the Company issued a press release announcing several actions being undertaken in anticipation of the Meeting:
Sponsor
Contributions to Trust Account
If
the Extension is approved at the Meeting and implemented, the Company’s sponsor, Cactus Healthcare Management LP (the “Sponsor”),
or its designees will deposit into the Company’s trust account as a loan (a “Contribution”, and the Sponsor
or its designee making such Contribution, a “Contributor”), on the Original Termination Date, and on the 2nd
day of each subsequent calendar month until the Extension Date, the lesser of (x) $40,000 and (y) $0.02 per public share multiplied
by the number of public shares outstanding on such applicable date (each date on which a Contribution is to be deposited into the Company’s
trust account, a “Contribution Date”).
If
a Contributor fails to make a Contribution by an applicable Contribution Date (subject to a three business day grace period), the Company will liquidate and dissolve as soon as
practicable after such date and in accordance with the Company’s Articles. The Contributions will be evidenced by a
non-interest bearing, unsecured promissory note and will be repayable by the Company upon consummation of an initial business
combination. If the Company does not consummate an initial business combination by the Extension Date, any such promissory notes
will be repaid only from funds held outside of the trust account or will be forfeited, eliminated or otherwise forgiven. Any
Contribution is conditioned on the approval of the requisite proposals at the Meeting and the implementation of the Extension. No
Contribution will occur if such proposals are not approved or the Extension is not implemented. If the Company has consummated an
initial business combination or announced its intention to wind up prior to any Contribution Date, any obligation to make
Contributions will terminate.
Trust
Funds Will Not Be Withdrawn to Pay Excise Taxes
On
August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides
for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded
U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January
1, 2023. Any redemptions of public shares on or after January 1, 2023, including in connection with the Extension, may be subject to
such excise tax. The Company confirms that if the Extension is implemented, it will not withdraw any funds from the trust account, including
interest earned on the funds held in the trust account, to pay for the 1% excise tax that may become due under the IR Act.
Trust
Funds to Be Held in Interest-Bearing Account, if Liquidated
If
the Extension is implemented and the Company thereafter determines to liquidate the U.S. government treasury obligations or money market
funds held in the trust account, the Company intends to maintain the funds in the trust account in cash in an interest-bearing demand
deposit account at a national bank. Interest on such deposit account currently yields approximately 4.5% per annum, but
such deposit account carries a variable rate and the Company cannot assure investors that such rate will not decrease or increase significantly.
Class
B Ordinary Shares to Be Converted if Extension is Implemented
If
each of the Articles Extension Proposal, Trust Extension Proposal and Conversion Amendment Proposal is approved at the Meeting, the Sponsor,
as the sole holder of the Class B ordinary shares, has agreed to convert all Class B ordinary shares to Class A ordinary shares, on a
one-for-one basis, in accordance with the Company’s Articles, upon the implementation of the Extension (collectively, the “Class
B Conversion”). The Class B Conversion would be effected prior to the redemption of any public shares in connection with the
implementation of the Extension and would result in an additional 3,162,500 Class A ordinary shares outstanding. Notwithstanding the
Class B Conversion, the Sponsor, as well as the Company’s officers and directors, will be not entitled to receive any funds held
in the trust account with respect to any Class A ordinary shares issued to such holders as a result of the Class B Conversion.
Forward
Looking Statements
This
Current Report on Form 8-K includes “forward-looking statements” within the meaning of the safe harbor provisions of the
United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the
use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,”
“assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions.
Such statements may include, but are not limited to, statements regarding the approval of certain proposals at the Meeting, implementation
of the Extension or any Contributions to the trust account, any excise tax liabilities of the Company under the IR Act, liquidation of
any securities held in the trust account, placement of funds held in the trust account in an interest-bearing demand deposit account
being permitted by the trustee of the trust account or current or future interest rates on funds held in the trust account. These statements
are based on current expectations on the date of this Current Report on Form 8-K and involve a number of risks and uncertainties that
may cause actual results to differ significantly, including those risks set forth in the definitive proxy statement related to the Meeting
filed by the Company with the Securities and Exchange Commission (the “SEC”) on March 20, 2023 (the “Definitive
Proxy Statement”), the Company’s most recent Annual Report on Form 10-K and other documents filed with the SEC. Copies
of such filings are available at the SEC’s website at www.sec.gov. The Company does not assume any obligation to update or revise
any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance
on forward-looking statements.
Additional
Information and Where to Find It
Further
information related to attendance, voting and the proposals to be considered and voted on at the Meeting is described in the Definitive
Proxy Statement, which has been mailed to the Company’s shareholders of record as of the record date for the Meeting. Investors
and security holders of the Company are advised to read the Definitive Proxy Statement because it contains important information about
the Meeting and the Company. Investors and security holders of the Company may also obtain a copy of the Definitive Proxy Statement,
as well as other relevant documents that have been or will be filed by the Company with the SEC, without charge and once available, at
the SEC’s website at www.sec.gov or by directing a request to: Stephen T. Wills, Chief Financial Officer, c/o Cactus Acquisition
Corp. 1 Ltd., 4B Cedar Brook Drive, Cranbury, NJ 08512, email: swills@cactususac1.com; telephone: (609) 495-2222.
Participants
in the Solicitation
The
Company and certain of its directors and executive officers and other persons may be deemed to be participants in the solicitation of
proxies from the Company’s stockholders in respect of the proposals to be considered and voted on at the Meeting. Information concerning
the interests of the directors and executive officers of the Company is set forth in the Definitive Proxy Statement, which may be obtained
free of charge from the sources indicated above.